The estimated Net Worth of Patrick Schmitz is at least $1.45 Million dollars as of 28 February 2020. Mr. Schmitz owns over 42,884 units of Nevro Corp stock worth over $289,863 and over the last 9 years he sold NVRO stock worth over $0. In addition, he makes $1,159,400 as Vice President - Operations at Nevro Corp.
Patrick has made over 1 trades of the Nevro Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 42,884 units of NVRO stock worth $2,862,507 on 28 February 2020.
The largest trade he's ever made was exercising 42,884 units of Nevro Corp stock on 28 February 2020 worth over $2,862,507. On average, Patrick trades about 3,899 units every 0 days since 2016. As of 28 February 2020 he still owns at least 61,542 units of Nevro Corp stock.
You can see the complete history of Mr. Schmitz stock trades at the bottom of the page.
Patrick Schmitz is the Vice President - Operations of the Company. From 2005 to October 2015, Mr. Schmitz served as Vice President, Operations at Thoratec, a medical device company, where he oversaw all domestic and international operations. From 2003 to 2005, Mr. Schmitz served as Vice President, North American Operations at GN ReSound, a medical device company. Mr. Schmitz also held several leadership positions in increasing levels of responsibility at St. Jude from 1993 to 2003. Mr. Schmitz holds a B.S. in Industrial Technology from the University of Wisconsin – Stout.
As the Vice President - Operations of Nevro Corp, the total compensation of Patrick Schmitz at Nevro Corp is $1,159,400. There are 5 executives at Nevro Corp getting paid more, with D.Keith Grossman having the highest compensation of $13,877,700.
Patrick Schmitz is 60, he's been the Vice President - Operations of Nevro Corp since 2016. There are 10 older and 11 younger executives at Nevro Corp. The oldest executive at Nevro Corp is Frank Fischer, 78, who is the Independent Director.
Patrick's mailing address filed with the SEC is C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY, CA, 94065.
Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo, and & Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.
headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.
Nevro Corp executives and other stock owners filed with the SEC include: